MyHealth Login    |    Bill Pay    |    Classes & Events         



Clinical Trials at Alegent Creighton Health

Print

Alegent Health Research Center is a keystone of Alegent Health's vision to be a leader among America's best health systems. Through clinical research, physicians at Alegent Health may offer their patients innovative, emerging treatments that are not currently available elsewhere. Participants in clinical trials play an active role in their own healthcare, gain access to new research treatments before they are widely available and help others by contributing to medical research.

What is a Clinical Trial?

A clinical trial (also clinical research) is a research study in human volunteers to answer specific health questions. Carefully conducted clinical trials are the fastest and safest way to find treatments that work in people.

Interventional trials determine whether experimental treatments or new ways of using known therapies are safe and effective under controlled environments. Observational trials address health issues in large groups of people or populations in natural settings.  More about clinical trials

Clinical trials are ongoing and some may not be listed. If you have any questions please email the Alegent Health Research office or call 402-343-8511.

Condition Description Disease Site
Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN) (Ref number:161) Heart
Boehringer Ingelheim Pharmaceuticals, Inc., “GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic TReatment In PAtients with Atrial Fibrillation” (Phase II/III)  (Ref number:162) Heart
An open-label, multicenter phase II study to examine the efficacy and safety of everolimus as second-line therapy in the treatment of patients with metastatic renal cell carcinoma (RECORD-4) (Ref number:163) Renal Cell Cancer
Reveal-AF (Ref number:166) Heart
An open-label, phase II, single-arm study of everolimus in combination with letrozole in the treatment of postmenopausal women with estrogen receptor positive metastatic breast cancer (Ref number:167) Breast
Cardia ODYSSEY (Ref number:168)

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome

Heart
Cardiac MultiSENSE - Multisensor Chronic Evaluations in Ambulatory Heart Failure Patients  (Ref number:152)

The goal of the MultiSENSE study is to collect chronic information from multiple sensors in an implanted device for evaluation in heart failure patients. More Information

Heart
Cardiac TIMI 54- PEGASUS (Ref number:156)

This study is being carried out to see if a new drug called ticagrelor given twice daily in addition to the ASA therapy decreases the frequency of cardiovascular events (e.g., death from heart disease, heart attack, or stroke). More Information

Heart
Cardiac REDUCE-IT (Reduction of Cardiovascular Events with EPA - Intervention Trial) (Ref number:159)

A Multi-Center, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group STudy to Evaluate the Effect of AMR101 on Cardiovascular Health and Mortality in Hypertriglyceridemic Patients with Cardiovascular Disease or at High Risk for Cardiovascular Disease: REDUCE-IT (Reduction of Cardiovascular Events with EPA - Intervention Trial)

Heart
Cardiac OptimumTM Lead Insulation Material (Optimum) Registry (Ref number:154)



Heart
Chest Pain PROMISE- Prospective Multi-center Imaging Study  (Ref number:151)

A prospective multicenter imaging study for evaluation of chest pain. Objective is to determine whether an initial non-invasive anatomic imaging strategy with coronary CT angiography (CTA) will improve clinical outcomes in subjects with symptoms concerning for coronary artery disease relative to an initial functional testing strategy (usual care). More Information

Heart
Device Monitoring The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients with ICD and CRT-D Devices (Ref number:149)

The IMPACT Study will investigate the potential clinical benefit of the combined use of BIOTRONIK Home Monitoring (HM) technology and a predefined anticoagulation plan compared to conventional device evaluation and physician-directed anticoagulation in patients with implanted dual-chamber defibrillators or cardiac resynchronization therapy devices. More Information

Heart
Device Replacement Centurion, A Multicenter, Prospective Registry: AIGISRxTM Antibacterial Envelope for Prevention of Infection Following Cardiac Rhythm Management Device Replacement with a Cardiac Resnychronization Therapy Device (CRT) (Ref number:147)



Heart
Device Replacement CITADEL- A Multicenter, Prospective Registry: AIGISRxTM Anti-Bacterial Envelope for Prevention of Infection Following Cardiac Rhythm Management Device Replacement with an Implantable Cardioverter-Defibrillator Device (ICD) (Ref number:148)



Heart
Endometriosis A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Elagolix in Subjects with Moderate to Severe Endometriosis-Associated Pain (Ref number:160)
For patients who suffer from disabling headaches PFO- PREMIUM Research Study for an Investigational Device (Ref number:141)

Alegent Health Research Center is conducting a trial for patients with disabling migraine headaches. The research study is designed to evaluate the safety and effectiveness of an investigational device as a treatment for migraine in subjects who are refractory to medical treatment. Download a flyer. More Information

Head & Neck
Pacemaker Accent MRI pacemaker and Tendril MRI lead IDE study (Ref number:164) Heart
Type 2 Diabetes Dual III - The efficacy of insulin degludec/liraglutide in controlling glycemia in adults with type 2 diabetes inadequately controlled on GLP-1 receptor agonist and metformin therapy (Ref number:165) Pancreas
Type 2 Diabetes A Randomized, Placebo-controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment with Exenatide Once Weekly in Patients with Type 2 Diabetes Mellitus (Ref number:155)



Pancreas
 
  Phone Directory Contact Us Alegent Creighton Health Blog Like Alegent Creighton Health on Facebook Follow Alegent Creighton Health on Twitter Alegent Creighton Health YouTube Channel LinkedIn Alegent Creighton Health RSS Feeds Alegent Creighton Health Mobile  
 
  SITE INFORMATION
Catholic Health Initiatives
Contact Us
Feedback
Patient Privacy Notice
Site Map
Terms of Use
Website Privacy
LOCATIONS
Alegent Creighton Clinic
Alegent Creighton Health Quick Care
Bergan Mercy Medical Center
Community Memorial Hospital
Creighton University Medical Center
Immanuel Medical Center
Lakeside Hospital
Lasting Hope Recovery Center
Memorial Hospital - Schuyler
Mercy Hospital
Mercy Hospital - Corning, IA
Midlands Hospital
Plainview Hospital
RESOURCES
Appointments
Baby Photos
Bill Pay
Classes & Events
Employees
eNewsletter
Find a Physician
Health Information
Health News
Jobs
Mobile
My Cost
News Center
Vendor Information
MEDICAL SERVICES
Back & Spine
Cancer
Children's Health
Emergency Departments
Heart & Vascular
Maternity
Mental Health
Neuroscience
Orthopedics
Pharmacy
Physical Rehabilitation
Senior Services
Weight Management
Women's Health
PATIENT AND VISITOR INFORMATION
Advance Directives
Awards and Recognition
Contáctenos
Español
Faith at Alegent Creighton
Financial Assistance
Gift Shops
Language Access
Pastoral Care
Patient Rights
Patients & Visitors

Make a Donation to Alegent Creighton Health

© 2013 Alegent Creighton Health. All rights reserved